Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 363

1.

Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury.

Chang CP, Chio CC, Cheong CU, Chao CM, Cheng BC, Lin MT.

Clin Sci (Lond). 2013 Feb;124(3):165-76. doi: 10.1042/CS20120226.

PMID:
22876972
2.

Effects of secretome obtained from normoxia-preconditioned human mesenchymal stem cells in traumatic brain injury rats.

Chuang TJ, Lin KC, Chio CC, Wang CC, Chang CP, Kuo JR.

J Trauma Acute Care Surg. 2012 Nov;73(5):1161-7. doi: 10.1097/TA.0b013e318265d128.

PMID:
22976425
3.

Neurotrophic and neuroprotective potential of human limbus-derived mesenchymal stromal cells.

Liang CM, Weng SJ, Tsai TH, Li IH, Lu PH, Ma KH, Tai MC, Chen JT, Cheng CY, Huang YS.

Cytotherapy. 2014 Oct;16(10):1371-83. doi: 10.1016/j.jcyt.2014.05.015. Epub 2014 Jul 2.

PMID:
24996595
4.

IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats.

Wei X, Du Z, Zhao L, Feng D, Wei G, He Y, Tan J, Lee WH, Hampel H, Dodel R, Johnstone BH, March KL, Farlow MR, Du Y.

Stem Cells. 2009 Feb;27(2):478-88. doi: 10.1634/stemcells.2008-0333.

5.

Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production.

Chen X, Katakowski M, Li Y, Lu D, Wang L, Zhang L, Chen J, Xu Y, Gautam S, Mahmood A, Chopp M.

J Neurosci Res. 2002 Sep 1;69(5):687-91.

PMID:
12210835
6.

Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.

Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR.

Shock. 2010 Jan;33(1):24-30. doi: 10.1097/SHK.0b013e3181b7d137.

PMID:
19996917
8.

Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.

Lan YW, Choo KB, Chen CM, Hung TH, Chen YB, Hsieh CH, Kuo HP, Chong KY.

Stem Cell Res Ther. 2015 May 20;6:97. doi: 10.1186/s13287-015-0081-6.

9.
10.

The interactions between brain microvascular endothelial cells and mesenchymal stem cells under hypoxic conditions.

Liu K, Chi L, Guo L, Liu X, Luo C, Zhang S, He G.

Microvasc Res. 2008 Jan;75(1):59-67. Epub 2007 Jun 23.

PMID:
17662311
11.

Hypoxia/Reoxygenation-Preconditioned Human Bone Marrow-Derived Mesenchymal Stromal Cells Rescue Ischemic Rat Cortical Neurons by Enhancing Trophic Factor Release.

Kim YS, Noh MY, Cho KA, Kim H, Kwon MS, Kim KS, Kim J, Koh SH, Kim SH.

Mol Neurobiol. 2015 Aug;52(1):792-803. doi: 10.1007/s12035-014-8912-5. Epub 2014 Oct 8.

PMID:
25288154
12.

Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF.

Liu L, Gao J, Yuan Y, Chang Q, Liao Y, Lu F.

Cell Biol Int. 2013 Jun;37(6):551-60. doi: 10.1002/cbin.10097. Epub 2013 Apr 19.

PMID:
23505143
13.

Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival.

Li H, Zuo S, He Z, Yang Y, Pasha Z, Wang Y, Xu M.

Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1772-81. doi: 10.1152/ajpheart.00557.2010. Epub 2010 Sep 24.

14.

Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair.

Zisa D, Shabbir A, Suzuki G, Lee T.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):834-8. doi: 10.1016/j.bbrc.2009.10.058. Epub 2009 Oct 15.

15.

Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice.

Chen L, Xu Y, Zhao J, Zhang Z, Yang R, Xie J, Liu X, Qi S.

PLoS One. 2014 Apr 29;9(4):e96161. doi: 10.1371/journal.pone.0096161. eCollection 2014. Erratum in: PLoS One. 2015;10(12):e0145565.

16.

Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms.

Weil BR, Markel TA, Herrmann JL, Abarbanell AM, Meldrum DR.

Surgery. 2009 Aug;146(2):190-7. doi: 10.1016/j.surg.2009.03.031.

PMID:
19628073
17.

Mesenchymal stem cells treated with rat pancreatic extract secrete cytokines that improve the glycometabolism of diabetic rats.

Xu YX, Chen L, Hou WK, Lin P, Sun L, Sun Y, Dong QY, Liu JB, Fu YL.

Transplant Proc. 2009 Jun;41(5):1878-84. doi: 10.1016/j.transproceed.2009.01.087.

PMID:
19545749
18.

High passage number of stem cells adversely affects stem cell activation and myocardial protection.

Crisostomo PR, Wang M, Wairiuko GM, Morrell ED, Terrell AM, Seshadri P, Nam UH, Meldrum DR.

Shock. 2006 Dec;26(6):575-80.

PMID:
17117132
19.

Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury.

Yu X, Lu C, Liu H, Rao S, Cai J, Liu S, Kriegel AJ, Greene AS, Liang M, Ding X.

PLoS One. 2013 May 9;8(5):e62703. doi: 10.1371/journal.pone.0062703. Print 2013.

20.

Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing.

Li WY, Choi YJ, Lee PH, Huh K, Kang YM, Kim HS, Ahn YH, Lee G, Bang OY.

Cell Transplant. 2008;17(9):1045-59.

PMID:
19177841
Items per page

Supplemental Content

Write to the Help Desk